Aprea Therapeutics, Inc. (APRE) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Aprea Therapeutics, Inc. (APRE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.8M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 1.48 to the broader market. Aprea Therapeutics, Inc. Led by Oren Gilad, public since 2019-10-03.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for APRE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →